News Snapshot:
In addition to recipients of Sinovac Jab, Zhejiang officials said the Covid-19 vaccine developed by private pharmaceutical company Sinovac Biotech was made available to high-risk groups in eastern China under an emergency use plan. .. It is unknown exactly how many citizens received the jabs, but local and foreign media reports showed images of people lining up outside the Centers for Disease Control and Prevention to receive the jabs. … To justify the approval of an unproven vaccine, Beijing stated that the use of the product was restricted to high-risk individuals, but only to a clear group of front-line medical...
